human soluble receptor-Fc fusion protein that targets human activin A

	human soluble receptor-Fc fusion protein that targets human activin A
Trade Name
Orphan Indication	Ovarian cancer
USA Market Approval	USA
USA Designation Date	2015-10-14 00:00:00
Sponsor	Atara Biotherapeutics;4360 Park Terrace Drive, Suite 100;Westlake Village, California, 91361

Related Access Program

AstraZeneca – PSR Ovarian Cancer With a BRCA Mutation Tesaro, Inc. – Recurrent Ovarian Cancer AstraZeneca – Ovarian Cancer